Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume 7, Issue 12, Pages 700-702Publisher
BLACKWELL PUBLISHING LTD
DOI: 10.1046/j.1469-0691.2001.00341.x
Keywords
-
Categories
Ask authors/readers for more resources
The aim of this study was to determine the in vitro susceptibility of 170 clinical isolates of Mycobacterium tuberculosis to fusidic acid using a proportion dilution method. Nineteen isolates were resistant to at least one first line anti-tuberculosis drug. A total of 1.8% of the isolates were resistant to fusidic acid. Fusidic acid should be evaluated clinically as a potential supplementary drug for the treatment of infections due to multidrug-resistant strains of M. tuberculosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available